Top

Published in:

01-05-2023 | Tuberculosis | News item

Antituberculars: paradoxical reactions require revision of precautions

Published in: Reactions Weekly | Issue 1/2023

Excerpt

The Japanese Ministry of Health, Labour and Welfare (MHLW) has instructed marketing authorisation holders to revise Precautions for antitubercular agents, reports the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) in Pharmaceuticals and Medical Devices Safety Information . This follows the addition of a cautionary statement about a paradoxical drug reaction to Prescribing Information for antituberculars in the US. …

Revision of Precautions for Antitubercular Agents Pharmaceuticals and Medical Devices Safety Information : 8-9, No. 400, 20 Apr 2023. Available from: URL: https://www.pmda.go.jp/files/000252266.pdf#page=8

Title: Antituberculars: paradoxical reactions require revision of precautions
Publication date: 01-05-2023
Publisher: Springer International Publishing
Keywords: Tuberculosis
Mycobacterium Tuberculosis
Tuberculosis
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-38248-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Antituberculars: paradoxical reactions require revision of precautions

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Aripiprazole/AZD-1222/olanzapine

Benralizumab

Diclofenac

Bevacizumab/gefitinib

Reteplase

Antineoplastics